Share on StockTwits

GlaxoSmithKline plc (LON:GSK)‘s stock had its “hold” rating reaffirmed by equities research analysts at Deutsche Bank in a research note issued to investors on Monday, AnalystRatingsNetwork reports. They currently have a GBX 1,660 ($27.96) target price on the stock. Deutsche Bank’s target price points to a potential upside of 1.00% from the stock’s previous close.

A number of other firms have also recently commented on GSK. Analysts at Jefferies Group raised their price target on shares of GlaxoSmithKline plc from GBX 1,520 ($25.60) to GBX 1,585 ($26.70) in a research note on Wednesday, May 7th. They now have a “hold” rating on the stock. Separately, analysts at Bryan Garnier & Cie reiterated a “neutral” rating on shares of GlaxoSmithKline plc in a research note on Friday, May 2nd. They now have a GBX 1,755 ($29.56) price target on the stock. Finally, analysts at Credit Suisse reiterated an “underperform” rating on shares of GlaxoSmithKline plc in a research note on Thursday, May 1st. They now have a GBX 1,600 ($26.95) price target on the stock. Four research analysts have rated the stock with a sell rating, twelve have given a hold rating and eight have given a buy rating to the company. GlaxoSmithKline plc has a consensus rating of “Hold” and an average target price of GBX 1,723.78 ($29.03).

GlaxoSmithKline plc (LON:GSK) traded up 0.21% during mid-day trading on Monday, hitting GBX 1643.50. 9,961,830 shares of the company’s stock traded hands. GlaxoSmithKline plc has a 52 week low of GBX 1200.668 and a 52 week high of GBX 1816.00. The stock has a 50-day moving average of GBX 1605. and a 200-day moving average of GBX 1619.. The company’s market cap is £79.118 billion.

The company also recently declared a dividend, which is scheduled for Thursday, July 10th. Shareholders of record on Wednesday, May 14th will be given a dividend of GBX 19 ($0.32) per share. This represents a yield of 1.17%. The ex-dividend date of this dividend is Wednesday, May 14th.

GlaxoSmithKline plc (LON:GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.